Open Access NewsNews from the open access movement Jump to navigation |
|||
Elsevier and Wellcome come to an agreement
Elsevier has adopted a policy for authors whose research is funded by the Wellcome Trust. The key piece of background, of course, is that Wellcome mandates OA for Wellcome-funded research. Excerpt from Elsevier's new policy:
Comment. I've criticized publishers who charge authors for the right to comply with their own funding contracts. ("Authors shouldn't have to pay their publisher in order to live up to a contract with their funder.") But the circumstances change when the funder is willing to pay the fee charged by the publisher. As long as funders like Wellcome are willing to do this, and as long as the publisher fees are reasonably tied to the actual costs of an efficient operation, then this can be a win-win-win. Authors and funders get OA to their research; publishers get their expenses covered for providing it; and authors pay nothing out of pocket. There's a fourth party in the wings --subscribers-- who will win too if the publisher reduces subscription prices in proportion to author uptake of its OA option. There are still ways in which the deal can be improved. Elsevier could make the OA edition the same as the published edition. It could let participating authors retain copyright and use CC licenses (or equivalents) on the OA editions. It could let participating authors deposit their articles in any OA repository, not just their own IR. (For more background, see my June article on Elsevier's hybrid journal program, where I pointed out that the Elsevier terms conflicted with the Wellcome Trust's requirements.) If we conceive the funder-grantee contract to be independent of the author-publisher contract, then it looks like publisher fees are meddling in contracts to which publishers are not a party. But the Wellcome-Elsevier agreement suggests that these previously separate contracts are merging and that we will have to recognize a new kind of tripartite contract among authors, funders, and publishers. If so, publishers who enter these agreements can't complain when public policies to regulate access to publicly-funded research have the side-effect of regulating publishers, something they have been very touchy about in the past. |